Yep. Everything with this company ties in together so perfectly. Game changer unique drugs with a potentially GIANT valuation. top notch management and science team, excellent share structure and burn rate, and all the big industry connections you could dream of. Not to mention an impeccably written and powerful patent, that may one day cover the basis for many other uses. And then of course, Dana farber running the pivotal kevetrin trial. If you read the nuts and bolts of the protocol and see all the biomarker and secondary data we will accumulate, that will be exactly the ammo we use to make a very compelling and irrefutable case to the FDA that this is a game changer, and should be labeled as such by the government.
Market Data 
Markets 
AI
